USE OF GONADOTROPIN-RELEASING-HORMONE AGONIST BEFORE VAGINAL SURGERY FOR CERVICAL LEIOMYOMAS - A REPORT OF 2 CASES

Two cases of cervical myoma were treated with combined medical/surgica l therapy using,oa gonadotropin releasing hormone agonist (GnRH-a) and transvaginal cervical myomectomy. Patients were treated with depot Gn RH-a (leuprolide acetate) for two months followed by myomectomy. This approach allowed successful treatment with short hospitalization (<24 hours). potential benefits of this regimen include decreased intraoper ative blood loss, outpatient management, decreased morbidity, decrease d hospital expense and preservation of reproductive potential by avoid ing hysterectomy.